Board Meeting13 Aug 2026, 01:19 pm
Brawn Biotech Board Approves Q1 FY27 Un-audited Results
AI Summary
Brawn Biotech Ltd's Board of Directors met on August 13, 2026, and approved the un-audited financial results for the quarter ended June 30, 2026. The board also recommended the appointment of M/s GD S M and Co as Statutory Auditors for a five-year term. Additionally, the board approved convening the 41st Annual General Meeting on September 29, 2026, through VC/OAVM, and approved the Board's Report for the financial year ended March 31, 2026. The meeting commenced at 12:30 PM IST and concluded at 1:00 PM IST.
Key Highlights
- Board approved un-audited financial results for Q1 FY27.
- Recommended appointment of new statutory auditors for 5 years.
- AGM scheduled for September 29, 2026, via VC/OAVM.
- Approved Board's Report for FY26.
- Financial results and limited review report enclosed.
Price Impact
More from BRAWN